نتایج جستجو برای: hpv vaccines

تعداد نتایج: 68193  

2016
A.F. Nicol C.V. Andrade F.B. Russomano L.L.S. Rodrigues N.S. Oliveira D.W. Provance

Controversy still exists over whether the benefits of the available HPV vaccines outweigh the risks and this has suppressed uptake of the HPV vaccines in comparison to other vaccines. Concerns about HPV vaccine safety have led some physicians, healthcare officials and parents to withhold the recommended vaccination from the target population. The most common reason for not administering the pro...

Journal: :JPMA. The Journal of the Pakistan Medical Association 2009
Sadaf Yousuf Serajuddaula Syed

Human Papilloma Virus (HPV) associated cervical cancer is amongst the ten most common cancers in women in the developing world. New vaccines markedly reduce the economic burden of diseases on a country's health system. Two types of HPV vaccines are available; prophylactic and therapeutic. Prophylactic vaccines target (Late protein) L1 and to a lesser extent L2, which stimulate neutralizing anti...

Journal: :British medical bulletin 2008
Margaret Stanley

BACKGROUND The burden of human papillomavirus (HPV)-associated ano-genital disease is significant but the ability to generate HPV virus-like particles by the synthesis and self-assembly in vitro of the major virus coat protein L1 has transformed our prospects for preventing benign and malignant ano-genital disease caused by the common genital HPV types. SOURCES OF DATA Peer reviewed journals....

Journal: :Vaccine 2006
Laura A Koutsky Diane M Harper

Early data from randomized controlled trials consistently show that prophylactic human papillomavirus virus-like particle (HPV VLP) vaccines are effective in preventing infection and lesions caused by the targeted HPV type(s). Two vaccines, a bivalent HPV-16/18 VLP vaccine and a quadrivalent HPV-6/11/16/18 VLP vaccine, are currently undergoing evaluation in phase III trials with anticipation of...

2010
Barbara Ma Yijie Xu Chien-Fu Hung

The discovery of human papillomavirus (HPV) as a necessary etiological factor for cervical cancer has spurred the development of preventive and therapeutic HPV vaccines for the control of HPV-associated malignancies including cervical, vulvar, vaginal, and a subset of head and neck cancers. The commercial preventive HPV vaccines, Gardasil and Cervarix, use HPV virus-like particles to generate n...

Journal: :Preventive medicine 2015
Melissa B Gilkey Jennifer L Moss Tamera Coyne-Beasley Megan E Hall Parth D Shah Noel T Brewer

BACKGROUND Low human papillomavirus (HPV) vaccination coverage stands in stark contrast to our success in delivering other adolescent vaccines. To identify opportunities for improving physicians' recommendations for HPV vaccination, we sought to understand how the communication context surrounding adolescent vaccination varies by vaccine type. METHODS A national sample of 776 U.S. physicians ...

Journal: :Pediatrics 2006
Amanda F Dempsey Gregory D Zimet Robert L Davis Laura Koutsky

OBJECTIVES Prophylactic vaccines against human papillomavirus (HPV) are expected to be available for public use by 2007 and likely will be targeted to preadolescent children. Parental acceptance of these vaccines will be critical for their success. The objectives of this study were (1) to determine the overall acceptance of HPV vaccines for preadolescent children by parents, (2) to evaluate the...

2017
Eva McGhee Hill Harper Adaku Ume Melanie Baker Cheick Diarra John Uyanne Sebhat Afework Keosha Partlow Lucy Tran Judith Okoro Anh Doan Karen Tate Mechelle Rouse Meidrah Tyler Kamilah Evans Tonya Sanchez Ishmum Hasan Enijah Smith-Joe Jasmine Maniti Liliana Zarate Camille King Antoinette Alugbue Chiamaka Opara Bileko Wissa Joanne Maniti Roland Pattillo

The human papillomavirus (HPV) is a major public health concern affecting both females and males. HPV is associated with cervical, anal, head and neck cancers. About 99% of all cervical cancers are related to HPV. HPV vaccines, Gardasil, Cervarix, and Gardasil 9 are used in the primary prevention of HPV related cancers. Gardasil and Gardasil 9 are available for use in both females and males age...

Journal: :Frontiers in bioscience : a journal and virtual library 2007
Yen-Yu Lin Hannah Alphs Chien-Fu Hung Richard B S Roden T-C Wu

Human papillomavirus has been identified as an etiological factor for cervical cancer, anogenital cancers and a subset of head and neck cancers. These important observations suggest that HPV vaccines have potential in the prevention and treatment of cervical cancer and other HPV-associated malignancies. The HPV genome encodes two HPV late genes, L1 and L2, which form the viral capsid. Early vir...

2014
Vikrant C. Sangar Sweta T. Kothari Abhay S. Chowdhary

Human Papillomavirus (HPV) is the most common sexually transmitted disease which can infect different parts of the body including uterus. Cervical cancer is the second most common cancer among women worldwide. The HPV-related disease appears to be increasing but treatment is limited, difficult and insufficient with high relapse rate. This growth in disease burden had made the development of two...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید